Iovance Biotherapeutics (IOVA) Preferred Dividend Payments (2016)
Iovance Biotherapeutics (IOVA) posted quarterly Preferred Dividend Payments of $49.5 million for Q3 2016.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Preferred Dividend Payments (2016) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Preferred Dividend Payments for 1 consecutive years, with $49.5 million the latest figure, recorded in Q3 2016.
- In Q3 2016, Preferred Dividend Payments changed N/A year-over-year to $49.5 million; the TTM figure through Dec 2017 stood at $49.5 million (changed 0.0% YoY), while the FY2016 annual figure was $49.5 million, changed N/A from the prior year.
- Preferred Dividend Payments was little changed at $49.5 million in Q3 2016 per IOVA's latest filing.
- Across five years, Preferred Dividend Payments topped out at $49.5 million in Q3 2016 and bottomed at $49.5 million in Q3 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Iovance Biotherapeutics | 3.95 Bn | 3.66 Bn | 55.72 Mn | - |